Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Breast cancer metastasis to parasagittal meningioma: a case report and literature review].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2026
Same author

[Surgical treatment of frontal lobe glial tumors. Current state of the problem. Part III: clinical, neurophysiological and surgical nuances].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2026
Same author

[Comparison of the effect of DNA aptamers U31, GR20, GR200 and their combination with radiation therapy on the viability of human glioblastoma cells G22 and Sus\fP2].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2026
Same author

[Hypofractionated irradiation for intracranial meningiomas].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2026
Same author

[Primary lymphoma of the central nervous system].

Arkhiv patologii·2025
Same author

[Radiosurgery for neurosurgical diseases (by the 20th anniversary of neuroradiosurgery in Russia)].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2025

Related Experiment Video

Updated: Aug 10, 2025

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.5K

[Astrocytoma with 1p19q codeletion].

M V Ryzhova1, S A Galstyan1, L V Shishkina1

  • 1Burdenko Neurosurgical Center, Moscow, Russia.

Arkhiv Patologii
|February 14, 2023
PubMed
Summary

Isocitrate dehydrogenase (IDH1/2) gene mutations in astrocytomas are not always early events. Rare 1p19q codeletions occur in astrocytomas, and IDH-mutant tumors can present in childhood.

Keywords:
1p19q codeletionastrocytoma

More Related Videos

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

5.9K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.6K

Related Experiment Videos

Last Updated: Aug 10, 2025

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.5K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

5.9K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.6K

Area of Science:

  • Neuro-oncology
  • Molecular genetics
  • Cancer biology

Context:

  • Astrocytomas are primary brain tumors.
  • Recurrent tumors provide insights into tumor evolution.
  • IDH1/2 mutations and 1p19q codeletions are key glioma biomarkers.

Purpose:

  • To investigate the timing of IDH1/2 mutations in astrocytoma pathogenesis.
  • To determine the occurrence of 1p19q codeletions in astrocytomas.
  • To assess the presence of IDH-mutant gliomas in pediatric populations.

Summary:

  • A 10-year follow-up of a recurrent astrocytoma case challenges the assumption that IDH1/2 gene mutations are always early events in glioma development.
  • The study identified a rare instance of 1p19q codeletion in an astrocytoma, a genetic alteration typically associated with oligodendrogliomas.
  • The findings indicate that IDH-mutant gliomas can manifest in childhood, expanding the known spectrum of this tumor type.

Impact:

  • Revises understanding of glioma pathogenesis and molecular evolution.
  • Highlights the importance of comprehensive genetic profiling in astrocytomas.
  • Informs diagnostic and therapeutic strategies for pediatric and adult glioma patients.